{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:56:25Z","timestamp":1791633385535,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Louise Vehmeijer foundation"},{"name":"Jean Louis Bernardi foundation"},{"DOI":"10.13039\/100006639","name":"Grant Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006639","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Forwis(h)dom foundation"},{"name":"Virtutis Opus foundation"},{"DOI":"10.13039\/100022713","name":"PNC Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cgh.2025.05.011","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T02:48:12Z","timestamp":1749782892000},"page":"385-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["ALT Is an Effective Screening Tool for Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease in Children With Obesity and Overweight"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0214-988X","authenticated-orcid":false,"given":"Anne-Sophie R.","family":"Stroes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Draijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Chegary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Kreier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erim","family":"van Os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joery","family":"Goede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venje","family":"Boonstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Westerbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meeike","family":"Kusters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roosje","family":"Roelants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan G.","family":"Holleboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Benninga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart G.P.","family":"Koot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2025.05.011_bib1","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/HEP.0000000000000383","article-title":"Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019","volume":"78","author":"Hartmann","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2025.05.011_bib2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cgh.2022.04.014","article-title":"Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"21","author":"Ng","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.05.011_bib3","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2025.05.011_bib4","article-title":"A natural history study of paediatric non-alcoholic fatty liver disease over 10 years","volume":"5","author":"Draijer","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2025.05.011_bib5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1053\/j.gastro.2020.07.034","article-title":"NASH Clinical Research Network. Progression of fatty liver disease in children receiving standard of care lifestyle advice","volume":"159","author":"Xanthakos","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.05.011_bib6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cgh.2022.05.028","article-title":"Nonalcoholic Steatohepatitis Clinical Research Network. Incidence of type 2 diabetes in children with nonalcoholic fatty liver disease","volume":"21","author":"Newton","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.05.011_bib7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.jhep.2021.06.034","article-title":"Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality","volume":"75","author":"Simon","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2025.05.011_bib8","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/obr.12556","article-title":"Screening for non-alcoholic fatty liver disease in children: do guidelines provide enough guidance?","volume":"18","author":"Koot","year":"2017","journal-title":"Obes Rev"},{"key":"10.1016\/j.cgh.2025.05.011_bib9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2009.12.052","article-title":"SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease","volume":"138","author":"Schwimmer","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.05.011_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN Clinical Practice Guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the ECON and the NASPGHAN","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2025.05.011_bib11","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/HEP.0000000000001016","article-title":"Development and validation of pFIB scores for exclusion of significant liver fibrosis in pediatric MASLD","volume":"81","author":"Lefere","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2025.05.011_bib12","series-title":"Leidraad Obesitas Kinderartsen","author":"Akker van den","year":"2018"},{"key":"10.1016\/j.cgh.2025.05.011_bib13","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/apa.16502","article-title":"Evaluation of the feasibility of screening for paediatric non-alcoholic fatty liver disease","volume":"111","author":"Draijer","year":"2022","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.cgh.2025.05.011_bib14","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jpn3.12156","volume":"78","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2025.05.011_bib15","article-title":"Clinical Practice Guideline for the evaluation and treatment of children and adolescents with obesity","volume":"151","author":"Hampl","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.cgh.2025.05.011_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.292.6512.13","article-title":"Ultrasound scanning in the detection of hepatic fibrosis and steatosis","volume":"292","author":"Saverymuttu","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.cgh.2025.05.011_bib17","series-title":"Biostatistics: A Foundation for Analysis in the Health Sciences","first-page":"324","author":"Daniel","year":"1999"},{"key":"10.1016\/j.cgh.2025.05.011_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/hep.22376","article-title":"Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis","volume":"48","author":"Nobili","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2025.05.011_bib19","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.05.011_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10396-021-01106-1","article-title":"Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter","volume":"48","author":"Ferraioli","year":"2021","journal-title":"J Med Ultrason"},{"key":"10.1016\/j.cgh.2025.05.011_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.cgh.2025.05.011_bib22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2025.05.011_bib23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/apt.12518","article-title":"Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease","volume":"38","author":"Schwimmer","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2025.05.011_bib24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.dld.2009.02.048","article-title":"Elevated serum ALT in children presenting to the emergency unit: relationship with NAFLD","volume":"41","author":"Nobili","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2025.05.011_bib25","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/HEP.0000000000000644","article-title":"Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease","volume":"79","author":"Wang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2025.05.011_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jpn3.12230","article-title":"Fibrosis and steatotic liver disease in US adolescents according to the new nomenclature","volume":"79","author":"Ma","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2025.05.011_bib27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jhep.2023.04.025","article-title":"An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography","volume":"79","author":"Liang","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2025.05.011_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MPG.0b013e31826f2760","article-title":"Transient elastography is a useful noninvasive tool for the evaluation of fibrosis in paediatric chronic liver disease","volume":"56","author":"Fitzpatrick","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2025.05.011_bib29","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/liv.14908","article-title":"Diagnostic accuracy of fibrosis tests in children with non-alcoholic fatty liver disease: a systematic review","volume":"41","author":"Draijer","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2025.05.011_bib30","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/hep4.1983","article-title":"The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan-aspartate aminotransferase to predict severity of liver disease in children","volume":"6","author":"Chaidez","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2025.05.011_bib31","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jpeds.2013.04.044","article-title":"Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston Children\u2019s Hospital experience","volume":"163","author":"Lee","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.cgh.2025.05.011_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12887-019-1485-8","article-title":"Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard","volume":"19","author":"Shin","year":"2019","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.cgh.2025.05.011_bib33","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","article-title":"Ultrasound-based techniques for the diagnosis of liver steatosis","volume":"25","author":"Ferraioli","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.05.011_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12887-017-0868-y","article-title":"Dyslipidemia and reference values for fasting plasma lipid concentrations in Danish\/North-European White children and adolescents","volume":"17","author":"Nielsen","year":"2017","journal-title":"BMC Pediatr"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525004872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525004872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:42:58Z","timestamp":1779219778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356525004872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1542356525004872"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2025.05.011","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALT Is an Effective Screening Tool for Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease in Children With Obesity and Overweight","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2025.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}